AstraZeneca

Most recent

• 

  As battle over AstraZeneca looms, one lab in Slough shows mergers can work

  31 Aug 2014: The bid from Pfizer, now active again, has caused widespread anger. But another takeover 10 years ago was a different story, writes Julia Kollewe

• FTSE 100 hits seven week high on Draghi QE hints

  26 Aug 2014: Investors hope for more cheap central bank money, as global tensions ease

• Switzerland's Roche agrees to buy US biotech company InterMune

  25 Aug 2014: Multibillion-dollar consolidation of global pharmaceutical sector continues with another blockbuster

• FTSE ends positive week on a downbeat note but Vodafone climbs on bid talk

  22 Aug 2014:

  Apple climbs to another new peak after helping push S&P 500 to a record on Thursday

• FTSE flat ahead of central bankers meeting but bid talk lifts Vodafone and AstraZeneca

  22 Aug 2014: Investors cautious awaiting speeches in US from Federal Reserve and ECB bosses

• FTSE hits three week high with AstraZeneca boosted as US closes Brilinta probe

  19 Aug 2014: Leading shares move higher again as investors brush aside geopolitical worries

• FTSE finishes higher on Ukraine hopes while Arm lifted by Goldman buy note

  18 Aug 2014: Chip designer put on bank's conviction buy list while AstraZeneca recovers ground

• FTSE ends week on a low note, while GlaxoSmithKline suggested as Pfizer target

  1 Aug 2014: Analysts say Pfizer offer for Glaxo would have some merits if no deal with AstraZeneca

• AstraZeneca upgrades sales and profit forecasts

  31 Jul 2014:

  Britain's second-largest drugmaker, which fended off a takeover approach from US rival Pfizer, highlighted the progress made replenishing its pipeline of new therapies

• FTSE flags on Ukraine, Argentina and US interest rate concerns

  30 Jul 2014: But AstraZeneca gains on Spanish deal and talk of interest in Germany's Evotec

• AstraZeneca boosts its lung drugs power with $2bn Almirall deal

  30 Jul 2014: Deal aims to fill gaps in drug firm's portfolio in key area, with boss pledging to lift revenues by three-quarters by 2023

• FTSE dips on sanctions with Antofagasta falling but Barclays up 5%

  30 Jul 2014: Miner slips on worries about copper prices but bank soars after beating expectations

• FTSE 100 falters as Aberdeen and Royal Bank of Scotland fall back

  28 Jul 2014: Pharmaceuticals in spotlight on Reckitt demerger plan and GlaxoSmithKline commments

• Growing alarm as foreigners flock in for great British takeaway

  27 Jul 2014:

  Business secretary Vince Cable has promised to strengthen takeover rules following Pfizer's attempt to buy AstraZeneca. But foreigners are increasingly in control of everything from Premier League football to political party strategy

• Time Warner bid, Meggitt rumour and Chinese data give FTSE best day since March

  16 Jul 2014: Merger excitement and positive GDP figures from China put investors in buoyant mood

• Next
• 1
• 2
• 3
• 4
• 5

1-15 of 540 for AstraZeneca